PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2014

PHARMANIAGA BERHAD

Financial Year End

31/12/2014
Quarter3
Quarterly report for the financial period ended30/09/2014
The figureshave not been audited

Attachments

BURSA-Financial 0914.pdf
294 KB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2014

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/09/2014
30/09/2013
30/09/2014
30/09/2013
$$'000
$$'000
$$'000
$$'000
1Revenue
502,086
440,807
1,495,830
1,378,779
2Profit/(loss) before tax
24,945
13,461
87,726
59,990
3Profit/(loss) for the period
15,001
4,170
57,604
35,494
4Profit/(loss) attributable to ordinary equity holders of the parent
14,955
3,751
57,147
34,387
5Basic earnings/(loss) per share (Subunit)
5.78
1.45
22.07
13.28
6Proposed/Declared dividend per share (Subunit)
8.00
3.00
16.00
9.82


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.9600
1.8800
Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

CountryBase UnitSubunit
MalaysiaRinggitSen
United StatesDollarCent
United KingdomPoundPence


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced21 Nov 2014  
CategoryFinancial Results
Reference NoPB-141118-72143